7K8R
Crystal structure of an anti-SARS-CoV-2 human neutralizing antibody Fab fragment, C135
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | SSRL BEAMLINE BL12-1 |
Synchrotron site | SSRL |
Beamline | BL12-1 |
Temperature [K] | 100 |
Detector technology | PIXEL |
Collection date | 2020-06-19 |
Detector | DECTRIS EIGER X 16M |
Wavelength(s) | 1 |
Spacegroup name | P 41 |
Unit cell lengths | 102.258, 102.258, 53.325 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 47.280 - 2.000 |
R-factor | 0.1972 |
Rwork | 0.195 |
R-free | 0.23670 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 7bz5 |
RMSD bond length | 0.013 |
RMSD bond angle | 1.174 |
Data reduction software | XDS |
Data scaling software | xia2 |
Phasing software | PHASER |
Refinement software | PHENIX (1.17.1_3660) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 47.280 | 2.070 |
High resolution limit [Å] | 2.000 | 2.000 |
Rmerge | 0.085 | 2.130 |
Rpim | 0.035 | 0.889 |
Number of reflections | 72349 | 3071 |
<I/σ(I)> | 6.8 | |
Completeness [%] | 99.4 | |
Redundancy | 6.8 | |
CC(1/2) | 0.998 | 0.305 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 298 | 0.04 M potassium phosphate, 16% w/v PEG8000, 20% v/v glycerol |